Mignar 50mg

Mignar contains Miglitol, an oral alpha-glucosidase inhibitor for use in the management of non-insulin-dependent diabetes mellitus. It is available as a 50 mg tablet for oral use. Patients with type 2 diabetes can control their high blood sugar levels in the blood after every meal. Your doctor may prescribe it when other similar treatments and a restricted diet cannot gain over uncontrolled blood glucose. The medicine contains the active ingredient Miglitol, which lowers blood glucose by inhibiting the activity of the enzyme alpha-glucosidase in the gastrointestinal tract, resulting in delayed glucose absorption. The anti-diabetic agent lower blood glucose in diabetic patients, especially postprandial hyperglycemia. It is a part of a treatment program that should also include a balanced diet, regular exercise and weight reduction measures as advised by the doctor. Because its mode of action is different, the effect of Miglitol to control blood glucose is additive to that of sulfonylureas drug when used in combination. In addition, this oral alpha-glucosidase inhibitor reduces the effects of sulfonylureas.